IBDClub |June 2023| Vedolizumab vs. Ustekinumab in Crohn's Disease

Fnu Vikash, PGY-1 Resident, Jacobi Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA, reviews the article 'Real-World Evidence Comparing Vedolizumab & Ustekinumab in Antitumor Necrosis Factor-Experienced Patients w/ Crohn's Disease.' The article was published in American Journal of Gastroenterology in April 2023 and can be accessed here: https://bit.ly/3W3CHqO